{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T16:35:07Z","timestamp":1792859707554,"version":"4.5.0"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,18]],"date-time":"2021-10-18T00:00:00Z","timestamp":1634515200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008392","name":"Sundhed og Sygdom, Det Frie Forskningsr\u00e5d","doi-asserted-by":"publisher","award":["1030-00070B"],"award-info":[{"award-number":["1030-00070B"]}],"id":[{"id":"10.13039\/100008392","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008392","name":"Sundhed og Sygdom, Det Frie Forskningsr\u00e5d","doi-asserted-by":"publisher","award":["4183-00118A"],"award-info":[{"award-number":["4183-00118A"]}],"id":[{"id":"10.13039\/100008392","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013696","name":"Fondo Nacional de Ciencia y Tecnolog\u00eda","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013696","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002848","name":"Comisi\u00f3n Nacional de Investigaci\u00f3n Cient\u00edfica y Tecnol\u00f3gica","doi-asserted-by":"publisher","award":["AFB170005"],"award-info":[{"award-number":["AFB170005"]}],"id":[{"id":"10.13039\/501100002848","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100016011","name":"Centro de Envejecimiento y Regeneraci\u00f3n, Pontificia Universidad Cat\u00f3lica de Chile","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100016011","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002850","name":"Fondo Nacional de Desarrollo Cient\u00edfico y Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["1191145"],"award-info":[{"award-number":["1191145"]}],"id":[{"id":"10.13039\/501100002850","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Fonden","doi-asserted-by":"publisher","award":["0058419"],"award-info":[{"award-number":["0058419"]}],"id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Fonden","doi-asserted-by":"publisher","award":["14040"],"award-info":[{"award-number":["14040"]}],"id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008363","name":"Kr\u00e6ftens Bek\u00e6mpelse","doi-asserted-by":"publisher","award":["R167-A10784"],"award-info":[{"award-number":["R167-A10784"]}],"id":[{"id":"10.13039\/100008363","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008363","name":"Kr\u00e6ftens Bek\u00e6mpelse","doi-asserted-by":"publisher","award":["R278-A16638"],"award-info":[{"award-number":["R278-A16638"]}],"id":[{"id":"10.13039\/100008363","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008363","name":"Kr\u00e6ftens Bek\u00e6mpelse","doi-asserted-by":"publisher","award":["R98-A6446"],"award-info":[{"award-number":["R98-A6446"]}],"id":[{"id":"10.13039\/100008363","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012440","name":"Berrikuntza + Ikerketa + Osasuna Eusko Fundazioa","doi-asserted-by":"publisher","award":["BIO15\/CA\/016\/BD"],"award-info":[{"award-number":["BIO15\/CA\/016\/BD"]}],"id":[{"id":"10.13039\/501100012440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["CON14\/00129"],"award-info":[{"award-number":["CON14\/00129"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["CPII19\/00008"],"award-info":[{"award-number":["CPII19\/00008"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI18\/01075"],"award-info":[{"award-number":["PI18\/01075"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006364","name":"Institut National Du Cancer","doi-asserted-by":"publisher","award":["BB-0033-00085"],"award-info":[{"award-number":["BB-0033-00085"]}],"id":[{"id":"10.13039\/501100006364","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002924","name":"Federaci\u00f3n Espa\u00f1ola de Enfermedades Raras","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002924","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003329","name":"Ministerio de Econom\u00eda y Competitividad","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003329","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003989","name":"Ikerbasque, Basque Foundation for Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003989","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["EBioMedicine"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.ebiom.2021.103661","type":"journal-article","created":{"date-parts":[[2021,10,28]],"date-time":"2021-10-28T23:13:55Z","timestamp":1635462835000},"page":"103661","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":86,"special_numbering":"C","title":["The altered serum lipidome and its diagnostic potential for Non-Alcoholic Fatty Liver (NAFL)-associated hepatocellular carcinoma"],"prefix":"10.1016","volume":"73","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5275-992X","authenticated-orcid":false,"given":"Monika","family":"Lewinska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alvaro","family":"Santos-Laso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enara","family":"Arretxe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Alonso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ekaterina","family":"Zhuravleva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raul","family":"Jimenez-Ag\u00fcero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Eizaguirre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Jes\u00fas","family":"Pareja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8494-8947","authenticated-orcid":false,"given":"Manuel","family":"Romero-G\u00f3mez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Arrese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malte P.","family":"Suppli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filip K.","family":"Knop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stine Karlsen","family":"Oversoe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerda Elisabeth","family":"Villadsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Decaens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flair Jose","family":"Carrilho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia PMS","family":"de Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Sangro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4748-0326","authenticated-orcid":false,"given":"Rocio I.R.","family":"Macias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesus M.","family":"Banales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1760-5244","authenticated-orcid":false,"given":"Jesper B.","family":"Andersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ebiom.2021.103661_bib0001","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","article-title":"Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention","volume":"15","author":"Younossi","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"5","key":"10.1016\/j.ebiom.2021.103661_bib0002","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1002\/hep.28785","article-title":"The economic and clinical burden of nonalcoholic fatty liver disease in the United States and Europe","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.ebiom.2021.103661_bib0003","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1146\/annurev-pathol-012615-044224","article-title":"Nonalcoholic Fatty Liver Disease: Pathogenesis and Disease Spectrum","volume":"11","author":"Hardy","year":"2016","journal-title":"Annu Rev Pathol"},{"key":"10.1016\/j.ebiom.2021.103661_bib0004","article-title":"Association between non-alcoholic fatty liver disease and cancer incidence rate","author":"Kim","year":"2017","journal-title":"J Hepatol"},{"issue":"10","key":"10.1016\/j.ebiom.2021.103661_bib0005","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/s41575-019-0186-y","article-title":"A global view of hepatocellular carcinoma: trends, risk, prevention and management","volume":"16","author":"Yang","year":"2019","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.ebiom.2021.103661_bib0006","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1007\/s10620-019-05537-2","article-title":"Disease Burden of Hepatocellular Carcinoma: A Global Perspective","volume":"64","author":"Sayiner","year":"2019","journal-title":"Dig Dis Sci"},{"issue":"2","key":"10.1016\/j.ebiom.2021.103661_bib0007","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.cld.2015.01.012","article-title":"Nonalcoholic Fatty liver disease, diabetes, obesity, and hepatocellular carcinoma","volume":"19","author":"Noureddin","year":"2015","journal-title":"Clin Liver Dis"},{"issue":"9","key":"10.1016\/j.ebiom.2021.103661_bib0008","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1111\/apt.14261","article-title":"Temporal trends, clinical patterns and outcomes of NAFLD-related HCC in patients undergoing liver resection over a 20-year period","volume":"46","author":"Pais","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.ebiom.2021.103661_bib0009","doi-asserted-by":"crossref","DOI":"10.1038\/s41575-019-0145-7","article-title":"From NASH to HCC: current concepts and future challenges","author":"Anstee","year":"2019","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.ebiom.2021.103661_bib0010","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1080\/17474124.2019.1549989","article-title":"Trends in hepatocellular carcinoma due to non-alcoholic fatty liver disease","volume":"13","author":"Bertot","year":"2019","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.ebiom.2021.103661_bib0011","article-title":"Incidence of Hepatocellular Carcinoma in Patients with Nonalcoholic Fatty Liver Disease: A Systematic Review, Meta-analysis, and Meta-regression","author":"Orci","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.ebiom.2021.103661_bib0012","doi-asserted-by":"crossref","DOI":"10.1038\/s41586-021-03362-0","article-title":"NASH limits anti-tumour surveillance in immunotherapy-treated HCC","author":"Pfister","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.ebiom.2021.103661_bib0013","doi-asserted-by":"crossref","DOI":"10.1038\/s41586-021-03233-8","article-title":"Auto-aggressive CXCR6+ CD8 T cells cause liver immune pathology in NASH","author":"Dudek","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.ebiom.2021.103661_bib0014","article-title":"Molecular characterization of hepatocellular carcinoma in patients with non-alcoholic steatohepatitis","author":"Pinyol","year":"2021","journal-title":"J Hepatol"},{"issue":"7747","key":"10.1016\/j.ebiom.2021.103661_bib0015","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/s41586-019-0984-y","article-title":"An integrative systems genetic analysis of mammalian lipid metabolism","volume":"567","author":"Parker","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.ebiom.2021.103661_bib0016","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhep.2021.04.013","article-title":"Hepatic lipidomic remodeling in severe obesity manifests with steatosis and does not evolve with non-alcoholic steatohepatitis","author":"Ooi","year":"2021","journal-title":"J Hepatol"},{"issue":"9859","key":"10.1016\/j.ebiom.2021.103661_bib0017","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1016\/S0140-6736(12)61729-2","article-title":"Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010","volume":"380","author":"Vos","year":"2012","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.ebiom.2021.103661_bib0018","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.cmet.2018.09.022","article-title":"Profound Perturbation of the Metabolome in Obesity Is Associated with Health Risk","volume":"29","author":"Cirulli","year":"2019","journal-title":"Cell Metab"},{"issue":"12","key":"10.1016\/j.ebiom.2021.103661_bib0019","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1038\/s41387-017-0003-z","article-title":"Ethnic differences in metabolite signatures and type 2 diabetes: a nested case-control analysis among people of South Asian, African and European origin","volume":"7","author":"van Valkengoed","year":"2017","journal-title":"Nutr Diabetes"},{"issue":"2","key":"10.1016\/j.ebiom.2021.103661_bib0020","doi-asserted-by":"crossref","first-page":"639","DOI":"10.2337\/db12-0495","article-title":"Identification of serum metabolites associated with risk of type 2 diabetes using a targeted metabolomic approach","volume":"62","author":"Floegel","year":"2013","journal-title":"Diabetes"},{"issue":"12","key":"10.1016\/j.ebiom.2021.103661_bib0021","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1038\/s41575-019-0217-8","article-title":"Metabolic rearrangements in primary liver cancers: cause and consequences","volume":"16","author":"Satriano","year":"2019","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.ebiom.2021.103661_bib0022","doi-asserted-by":"crossref","DOI":"10.1016\/S0168-8278(18)30365-9","article-title":"Serum metabolites as diagnostic biomarkers for cholangiocarcinoma, hepatocellular carcinoma and primary sclerosing cholangitis","author":"Banales","year":"2018","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.ebiom.2021.103661_bib0023","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1021\/pr201223p","article-title":"Obesity-dependent metabolic signatures associated with nonalcoholic fatty liver disease progression","volume":"11","author":"Barr","year":"2012","journal-title":"J Proteome Res"},{"issue":"Pt B","key":"10.1016\/j.ebiom.2021.103661_bib0024","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.jprot.2015.01.019","article-title":"Enhancing metabolomics research through data mining","volume":"127","author":"Martinez-Arranz","year":"2015","journal-title":"J Proteomics"},{"issue":"7","key":"10.1016\/j.ebiom.2021.103661_bib0025","first-page":"1327","article-title":"Cancer Genome Atlas Research Network. Electronic address wbe, Cancer Genome Atlas Research N. Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma","volume":"169","year":"2017","journal-title":"Cell"},{"issue":"W1","key":"10.1016\/j.ebiom.2021.103661_bib0026","doi-asserted-by":"crossref","first-page":"W486","DOI":"10.1093\/nar\/gky310","article-title":"Metaboanalyst 4.0: towards more transparent and integrative metabolomics analysis","volume":"46","author":"Chong","year":"2018","journal-title":"Nucleic Acids Res"},{"issue":"11","key":"10.1016\/j.ebiom.2021.103661_bib0027","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1005752","article-title":"mixOmics: An R package for 'omics feature selection and multiple data integration","volume":"13","author":"Rohart","year":"2017","journal-title":"PLoS Comput Biol"},{"issue":"3","key":"10.1016\/j.ebiom.2021.103661_bib0028","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1001113","article-title":"Consensus-phenotype integration of transcriptomic and metabolomic data implies a role for metabolism in the chemosensitivity of tumour cells","volume":"7","author":"Cavill","year":"2011","journal-title":"PLoS Comput Biol"},{"key":"10.1016\/j.ebiom.2021.103661_bib0029","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.copbio.2016.10.003","article-title":"Using lipidomics analysis to determine signalling and metabolic changes in cells","volume":"43","author":"Nguyen","year":"2017","journal-title":"Curr Opin Biotechnol"},{"issue":"3","key":"10.1016\/j.ebiom.2021.103661_bib0030","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s10555-005-5135-2","article-title":"Review of Growth Inhibitory Peptide as a biotherapeutic agent for tumor growth, adhesion, and metastasis","volume":"24","author":"Muehlemann","year":"2005","journal-title":"Cancer Metastasis Rev"},{"issue":"3","key":"10.1016\/j.ebiom.2021.103661_bib0031","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1158\/1055-9965.EPI-18-0281","article-title":"GALAD Score for Hepatocellular Carcinoma Detection in Comparison with Liver Ultrasound and Proposal of GALADUS Score","volume":"28","author":"Yang","year":"2019","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"15","key":"10.1016\/j.ebiom.2021.103661_bib0032","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10153392","article-title":"The APAC Score: A Novel and Highly Performant Serological Tool for Early Diagnosis of Hepatocellular Carcinoma in Patients with Liver Cirrhosis","volume":"10","author":"Lambrecht","year":"2021","journal-title":"J Clin Med"},{"issue":"11","key":"10.1016\/j.ebiom.2021.103661_bib0033","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1158\/1541-7786.MCR-11-0126","article-title":"Cancer cell dependence on unsaturated fatty acids implicates stearoyl-CoA desaturase as a target for cancer therapy","volume":"9","author":"Roongta","year":"2011","journal-title":"Mol Cancer Res"},{"issue":"2","key":"10.1016\/j.ebiom.2021.103661_bib0034","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1136\/gutjnl-2017-315448","article-title":"beta-catenin-activated hepatocellular carcinomas are addicted to fatty acids","volume":"68","author":"Senni","year":"2019","journal-title":"Gut"},{"issue":"9","key":"10.1016\/j.ebiom.2021.103661_bib0035","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1038\/s41419-020-03003-w","article-title":"Understanding lipotoxicity in NAFLD pathogenesis: is CD36 a key driver?","volume":"11","author":"Rada","year":"2020","journal-title":"Cell Death Dis"},{"issue":"suppl 1","key":"10.1016\/j.ebiom.2021.103661_bib0036","doi-asserted-by":"crossref","first-page":"e530s","DOI":"10.6061\/clinics\/2018\/e530s","article-title":"Eicosanoids and cancer","volume":"73","author":"Gomes","year":"2018","journal-title":"Clinics (Sao Paulo)"},{"key":"10.1016\/j.ebiom.2021.103661_bib0037","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/1476-511X-9-106","article-title":"Linoleic acid suppresses colorectal cancer cell growth by inducing oxidant stress and mitochondrial dysfunction","volume":"9","author":"Lu","year":"2010","journal-title":"Lipids Health Dis"},{"issue":"7593","key":"10.1016\/j.ebiom.2021.103661_bib0038","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/nature16969","article-title":"NAFLD causes selective CD4 (+) T lymphocyte loss and promotes hepatocarcinogenesis","volume":"531","author":"Ma","year":"2016","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.ebiom.2021.103661_bib0039","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1158\/1940-6207.CAPR-17-0249","article-title":"Metabolomics Profiles of Hepatocellular Carcinoma in a Korean Prospective Cohort: The Korean Cancer Prevention Study-II","volume":"11","author":"Jee","year":"2018","journal-title":"Cancer Prev Res (Phila)"},{"issue":"3","key":"10.1016\/j.ebiom.2021.103661_bib0040","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.cmet.2017.08.006","article-title":"Global Analysis of Plasma Lipids Identifies Liver-Derived Acylcarnitines as a Fuel Source for Brown Fat Thermogenesis","volume":"26","author":"Simcox","year":"2017","journal-title":"Cell Metab"},{"issue":"6","key":"10.1016\/j.ebiom.2021.103661_bib0041","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.3945\/jn.108.103754","article-title":"Plasma acylcarnitine profiles suggest incomplete long-chain fatty acid beta-oxidation and altered tricarboxylic acid cycle activity in type 2 diabetic African-American women","volume":"139","author":"Adams","year":"2009","journal-title":"J Nutr"},{"issue":"3","key":"10.1016\/j.ebiom.2021.103661_bib0042","doi-asserted-by":"crossref","first-page":"e00131","DOI":"10.14309\/ctg.0000000000000131","article-title":"Altered Microbiota Diversity and Bile Acid Signaling in Cirrhotic and Noncirrhotic NASH-HCC","volume":"11","author":"Sydor","year":"2020","journal-title":"Clin Transl Gastroenterol"},{"issue":"7","key":"10.1016\/j.ebiom.2021.103661_bib0043","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1002\/hep4.1188","article-title":"Metabolomic-based noninvasive serum test to diagnose nonalcoholic steatohepatitis: Results from discovery and validation cohorts","volume":"2","author":"Mayo","year":"2018","journal-title":"Hepatol Commun"},{"issue":"10","key":"10.1016\/j.ebiom.2021.103661_bib0044","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1016\/j.cgh.2016.05.046","article-title":"Noninvasive Detection of Nonalcoholic Steatohepatitis Using Clinical Markers and Circulating Levels of Lipids and Metabolites","volume":"14","author":"Zhou","year":"2016","journal-title":"Clin Gastroenterol Hepatol"}],"container-title":["EBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396421004552?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396421004552?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T19:12:22Z","timestamp":1762456342000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396421004552"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":44,"alternative-id":["S2352396421004552"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2021.103661","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The altered serum lipidome and its diagnostic potential for Non-Alcoholic Fatty Liver (NAFL)-associated hepatocellular carcinoma","name":"articletitle","label":"Article Title"},{"value":"EBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2021.103661","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"103661"}}